In the News
-
Shire files treatment protocol
08 July 2009
Shire has filed a treatment protocol for velaglucerase alfa for Gaucher Disease Lexington, Massachusetts, US – July 6th, 2009 – Shire plc (LSE: SHP...
Read more....
-
Protalix Approached by the FDA
05 July 2009
Protalix Approached by the FDA to Consider Submitting a Treatment Protocol for the Use of prGCD in Patients with Gaucher Disease Allowing Expanded Acc...
Read more....